Biocryst Pharmaceuticals BCRX
NASDAQ BCRX
$7.61 -0.18 (-2.25%)
As of: Oct 23, 2026 · 1:33 PM EDT

Biocryst Pharmaceuticals (BCRX) Short-Term Debt issuances (2019)

Updated

Biocryst Pharmaceuticals' Short-Term Debt issuances was $73.07 million in FY2022.

Analysis

Biocryst Pharmaceuticals (BCRX) Short-Term Debt issuances (2019) Analysis & Trends

From FY2016 onward, Biocryst Pharmaceuticals has reported Short-Term Debt issuances for 4 years.

  • Short-Term Debt issuances shows a four-year compound annual growth rate of 63.0% (FY2018 to FY2022).
  • The FY2022 figure marks the lowest annual Short-Term Debt issuances since FY2019.
  • Per Business Quant data, Short-Term Debt issuances in earlier years was $19.48 million in FY2019 (+88.1%) and $10.35 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Eli Lilly 1,138.00 Bn 1,106.58 Bn 19.71 Bn -
2 Johnson & Johnson 634.40 Bn 554.26 Bn 17.30 Bn 2.28 Bn
3 AbbVie 506.36 Bn 479.47 Bn 12.70 Bn -
4 Merck 358.30 Bn 312.68 Bn 12.21 Bn -
5 Novartis Ag 293.12 Bn 257.11 Bn 11.24 Bn -
6 Astrazeneca 265.36 Bn 239.05 Bn 12.86 Bn -
7 Amgen 238.40 Bn 193.80 Bn 7.24 Bn -
8 Gilead Sciences 195.15 Bn 169.35 Bn 6.22 Bn -
9 Pfizer 170.83 Bn 117.47 Bn 10.94 Bn -
10 Biocryst Pharmaceuticals 1.94 Bn 859.28 Mn 214.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 19.48 Mn
API Access

Biocryst Pharmaceuticals Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=BCRX&period=max&api_key=YOUR_API_KEY